68Ga-Based Radiopharmaceuticals: Production and Application Relationship

68Ga-Based Radiopharmaceuticals: Production and Application Relationship

The contribution of 68Ga to the promotion and expansion of clinical research and routine positron emission tomography (PET) for earlier better diagnostics and individualized medicine is considerable. The potential applications of 68Ga-comprising imaging agents include targeted, pre-targeted and non-...

Full description

Bibliographic Details
Main Author:	Irina Velikyan
Format:	Article
Language:	English
Published:	MDPI AG 2015-07-01
Series:	Molecules
Subjects:	positron emission tomography 68Ga chemistry receptor targeting peptide GMP dosimetry
Online Access:	http://www.mdpi.com/1420-3049/20/7/12913

Similar Items

Synthesis, Characterisation and Application of 68Ga-labelled Macromolecules
by: Velikyan, Irina
Published: (2005)

[<sup>68</sup>Ga]Ga-DOTA-TOC: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging
by: Ute Hennrich, et al.
Published: (2020-03-01)

Application of the 68Ge/68Ga Generator in Clinic
by: HUANG Qian-huan1;PAN Dong-hui2;XU Yu-ping2;SHENG Jie1;WANG Yan-ting2;YANG Min1,2
Published: (2017-04-01)

[<sup>68</sup>Ga]Ga-PSMA-11: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
by: Ute Hennrich, et al.
Published: (2021-07-01)

Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
by: Melissa E. Rodnick, et al.
Published: (2020-11-01)

68Ga-NOTA PET imaging for gastric emptying assessment in mice
by: Xueyan Chen, et al.
Published: (2021-02-01)

Application Progress of 68Ga-PSMA PET/CT in Recurrent Prostate Cancer
by: YANG Liping, et al.
Published: (2018-07-01)

Automated preparation of clinical grade [68Ga]Ga-DOTA-CP04, a cholecystokinin-2 receptor agonist, using iPHASE MultiSyn synthesis platform
by: Mohammad B. Haskali, et al.
Published: (2019-08-01)

Changes in biodistribution on 68Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression
by: Martin H. Cherk, et al.
Published: (2018-01-01)

68Ga-DOTATATE positron emission tomography/computed tomography to detect the recurrence of phosphaturic mesenhcymal tumor-induced osteomalacia
by: Manav I Bhalla, et al.
Published: (2020-01-01)

Metastatic clear cell renal cell carcinoma demonstrating intense uptake on 68Ga-DOTATATE positron emission tomography: Three case reports and a review of the literature
by: David P Nadebaum, et al.
Published: (2018-01-01)

[68Ga]/[188Re] Complexed [CDTMP] Trans-1,2-Cyclohexyldinitrilotetraphosphonic Acid As a Theranostic Agent for Skeletal Metastases
by: Ambika P. Jaswal, et al.
Published: (2017-06-01)

Evaluation of 68Ga-DOTA-Ubiquicidin (29–41) for imaging Staphylococcus aureus (Staph A) infection and turpentine-induced inflammation in a preclinical setting
by: Dilip Kumar Boddeti, et al.
Published: (2021-01-01)

68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography for prostate cancer imaging: A narrative literature review
by: Jose M Oliveira, et al.
Published: (2017-01-01)

GMP-compliant production of [68Ga]Ga-NeoB for positron emission tomography imaging of patients with gastrointestinal stromal tumor
by: Marc Pretze, et al.
Published: (2021-07-01)

Automated GMP-Compliant Production of [<sup>68</sup>Ga]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans
by: Michael Wagner, et al.
Published: (2020-07-01)

Otto: a 4.04 GBq (109 mCi) 68Ge/68Ga generator, first of its kind - extended quality control and performance evaluation in the clinical production of [68Ga]Ga-PSMA-11
by: Nicole N. Waterhouse, et al.
Published: (2020-02-01)

Extrapancreatic insulinoma
by: Robin Garg, et al.
Published: (2020-01-01)

Preclinical Studies of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs
by: mojdeh naderi, et al.
Published: (2016-01-01)

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
by: Matthias Eder, et al.
Published: (2014-06-01)

18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study
by: Silvia Taralli, et al.
Published: (2018-07-01)

New sensitive method for HEPES quantification in 68Ga-radiopharmaceuticals
by: I. F. Antunes, et al.
Published: (2020-05-01)

Prevalence of hitherto unknown brain meningioma detected on 68Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of177Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors
by: Rahul V Parghane, et al.
Published: (2019-01-01)

Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
by: Tarun Kumar Jain, et al.
Published: (2016-01-01)

Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings
by: Felipe de Galiza Barbosa, et al.
Published: (2020-03-01)

Diagnostic Performance of [<sup>18</sup>F]Fluorocholine and [<sup>68</sup>Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study
by: Zeinab Paymani, et al.
Published: (2020-07-01)

First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9
by: Silvano Gnesin, et al.
Published: (2018-12-01)

Correlation between standardized uptake value of 68Ga-DOTA-NOC positron emission tomography/computed tomography and pathological classification of neuroendocrine tumors
by: Chalermrat Kaewput, et al.
Published: (2018-01-01)

Incidental detection of asymptomatic brain metastases on 18F-fluoride positron emission tomography/computed tomography and 68Ga DOTANOC positron emission tomography/computed tomography in a patient with concomitant breast carcinoma and a pancreatic neuroendocrine tumor
by: Ruth Brown, et al.
Published: (2018-01-01)

Nuclear medicine technology for diagnosisof neuroendocrine tumors
by: D. V. Ryzhkova, et al.
Published: (2016-02-01)

Initial clinical experience with 68Ga-DOTA-NOC prepared using 68Ga from nanoceria-polyacrylonitrile composite sorbent-based 68Ge/68Ga generator and freeze-dried DOTA-NOC kits
by: Piyush Chandra, et al.
Published: (2017-01-01)

Quantitative PET/CT Imaging Based Biodistribution Validated in a Porcine Model using a Targeted Peptide Radiotracer, AMBA
by: Layman, Ricky R., Jr
Published: (2013)

Preparation and Quality Control of 68Ga-Citrate for PET Applications
by: Ayuob Aghanejad, et al.
Published: (2015-07-01)

Gallium radiopharmaceuticals 68
by: José Morín Zorrilla, et al.
Published: (2012-01-01)

Feasibility of Multiple Examinations Using 68Ga-Labelled Collagelin Analogues: Organ Distribution in Rat for Extrapolation to Human Organ and Whole-Body Radiation Dosimetry
by: Irina Velikyan, et al.
Published: (2016-06-01)

The Use of 68Ga-DOTATATE PET/CT in the Non-invasive Diagnosis of Optic Nerve Sheath Meningioma: A Case Report
by: Karine A. Al Feghali, et al.
Published: (2018-10-01)

Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals
by: Brendan J. Evans, et al.
Published: (2020-05-01)

[68Ga]Exendin-4: Bench-to-Bedside : PET molecular imaging of the GLP-1 receptor for diabetes and cancer
by: Selvaraju, Ram kumar
Published: (2015)

Padronização de Ga-68 em sistema de coincidências 4πβ-γ
by: Flavio William Lacerda
Published: (2013)

Padronização de Ga-68 em sistema de coincidências 4πβ-γ
by: Lacerda, Flavio William
Published: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rbkgfn64s01to1a3mmc54n6arq